Ascorbic acid serum levels are reduced in patients with hematological malignancies

Results in Immunology

Volumn 6, Issue , 2016, Pages 8-10

  Huijskens, Mirelle J A J ^a   Wodzig, Will K W H ^a   Walczak, Mateusz ^a   Germeraad, Wilfred T V ^a   Bos, Gerard M J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ascorbic acid; Chemotherapy; Hematological malignancy; Hematopoietic stem cell transplantation; Vitamin C

Indexed keywords

ASCORBIC ACID; BUSULFAN; CYCLOPHOSPHAMIDE; FERROUS ION; FLUDARABINE; MELPHALAN; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 84954549897     PISSN: None     EISSN: 22112839     Source Type: Journal    
DOI: 10.1016/j.rinim.2016.01.001     Document Type: Article

References (14)

1. Englard S., Seifter S. The biochemical functions of ascorbic acid. Annu. Rev. Nutr. 1986, 6:365-406.
2. Monfort A., Wutz A. Breathing-in epigenetic change with vitamin C. EMBO Rep. 2013, 14(4):337-346. 10.1038/embor.2013.29.
3. Strohle A., Wolters M., Hahn A. Micronutrients at the interface between inflammation and infection-ascorbic acid and calciferol. Part 2: calciferol and the significance of nutrient supplements. Inflamm. Allergy Drug Targets 2011, 10(1):64-74.
4. Bosch M., Dhadda M., Hoegh-Petersen M., Liu Y., Hagel L.M., Podgorny P., et al. Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation. Cytotherapy 2012, 14(10):1258-1275.
5. Huijskens M.J.A.J., Walczak M., Koller N., Briedé J., Senden-Gijsbers B.L.M.G., Schnijderberg M.C., et al. Ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells. J. Leukoc. Biol. 2014, 96(6):1165-1175. 10.1189/jlb.
6. Huijskens M.J.A.J., Walczak M., Sarkar S., Atrafi F., B.L.M.G.Senden-Gijsbers, Tilanus M., et al. Ascorbic acid promotes proliferation of NK cell populations in different culture systems applicable for NK cell therapy. Cytotherapy 2015, 17(5):613-620. 10.1016/j.jcyt.2015.01.004.
7. The Code for Proper Secondary Use of Human Tissue. , Nov 2014. http://www.federa.org/sites/default/files/bijlagen/coreon/codepropersecondaryuseofhumantissue1_0.pdf.
8. Schleicher R.L., Carroll M.D., Ford E.S., Lacher D.A. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES). Am. J. Clin. Nutr. 2009, 90(5):1252-1263.
9. Nannya Y., Shinohara A., Ichikawa M., Kurokawa M. Serial profile of vitamins and trace elements during the acute phase of allogeneic stem cell transplantation. Biol. Blood Marrow Transpl. 2014, 20(3):430-434.
10. Nitenberg G., Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit. Rev. Oncol. Hematol. 2000, 34(3):137-168.
11. Strohle A., Wolters M., Hahn A. Micronutrients at the interface between inflammation and infection--ascorbic acid and calciferol: part 1, general overview with a focus on ascorbic acid. Inflamm. Allergy Drug Targets 2011, 10(1):54-63.
12. H. Hooijkaas, K. Mohrmann, L. Smeets, J. Souverijn, Handboek medische laboratoriumdiagnostiek, tweede herziene druk, 2013.
13. Padayatty S.J., Sun H., Wang Y., Riordan H.D., Hewitt S.M., Katz A., et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann. Intern. Med. 2004, 140(7):533-537.
14. Kletzel M., Powers K., Hayes M. Scurvy: a new problem for patients with chronic GVHD involving mucous membranes; an easy problem to resolve. Pediatr. Transpl. 2014, 18(5):524-526.